Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: A double-blind, placebo-controlled, parallel group study

European Journal of Clinical Nutrition

Volumn 59, Issue SUPPL. 1, 2005, Pages

  Mathus Vliegen, E M H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

General practice; Sibutramine; Very low calorie diet (VLCD); Weight loss management; Weight loss treatment

Indexed keywords

PLACEBO; SIBUTRAMINE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; LONG TERM CARE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; OBESITY; PHYSICAL ACTIVITY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; APPETITE DEPRESSANTS; CYCLOBUTANES; DIET, REDUCING; DOUBLE-BLIND METHOD; ENERGY INTAKE; EXERCISE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NETHERLANDS; OBESITY; SAFETY; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 23944502313     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602172     Document Type: Article

References (22)

1. Anderson JW, Vichitbandra S, Qian W & Kryscio RJ (1999): Long-term weight maintenance after an intensive weight-loss program. J. Am. Coll. Nutr. 18, 620-627.
2. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F & Leutenegger E (1999): Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am. J. Med. 106, 179-184.
3. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML & Seaton TB (1999): Sibutramine produces dose-related weight loss. Obes. Res. 7, 189-198.
4. Dattilo AM & Kris-Etherton PM (1992): Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am. J. Clin. Nutr. 56, 320-328.
5. Garrow JS (1992): Treatment of obesity. Lancet 340, 409-413.
6. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH & Van Gaal LF (2000): Effect of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 356, 2119-2125.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA & Nathan DM (2002): Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403.
8. Lean ME (1997): Sibutramine - a review of clinical efficacy. Int. J. Obes. Relat. Metab. Disord. 21 (Suppl 1), S30-S36.
9. National Task Force on the Prevention and Treatment of Obesity and National Institutes of Health (1993): Very low-calorie diets. JAMA 270, 967-974.
10. National Task Force on the Prevention and Treatment of Obesity (1996): Long-term pharmacotherapy in the management of obesity. JAMA 276, 1907-1915.
11. National Heart, Lung and Blood Institute (1998): Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. NIH publication 98-4083. September 1998.
12. Royal College of Physicians (1998): Clinical management of overweight and obese patients with particular rererence to the use or drugs. RCP, 1998.
13. Royal College of Physicians of London (2003): Anti-obesity drugs: guidance on appropriate prescribing and management A report of the Nutrition Committee of the Royal College of Physicians of London. RCPL, April 2003.
14. Saris WH (2001): Very-low-calorie diets and sustained weight loss. Obes. Res. 9 (Suppl 4), 295S-301S.
15. Smith IG, Goulder MA & on behalf of the Members of the Sibutramine Clinical Study 1047 Team (2001): Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J. Fam. Pract. 50, 505-512.
16. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaaniemi S, Laakso M, Louheranta A, Rastas M, Salminen V & Uusitupa M (2001): Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350.
17. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T & Heath C (1995): Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am. J. Epidemiol. 141, 1128-1141.
18. World Health Organization (1985): Energy and protein requirements Report of a joint FAO/WHO/UNU expert consultation. Technical Reports Series 729. Geneva: World Health Organization.
19. World Health Organization (2000): Obesity: preventing and managing the global epidemic Report of a WHO consultation. WHO Technical Report Series 894. Geneva: WHO.
20. Tuck ML, Sowers J, Dornfeld L, Kledzik G & Maxwell M (1981): The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 304, 930-933.
21. UK prospective study of therapies of maturity-onset diabetes (1983): I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia 24, 404-411.
22. Wirth A & Krause J (2001): Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 286, 1331-1339.